Chain Biotechnology Limited
08841562
Notable Risks
- No accounts filed in last 18 months (-5)
- Going concern doubt noted in accounts (-10)
- Active insolvency proceedings (-20)
- 1 outstanding charge (-2)
Details
Compliance
Last accounts
31/12/2024
total exemption full
Next accounts due
30/09/2026
Confirmation statement
Last: 13/01/2026
Due 27/01/2027
Industry
Officers
director · Since 23/11/2023
CLINICAL CONSULTANT
BRITISH · UNITED KINGDOM · Age 49
Also on 3 other boards
director · Since 23/10/2024
SCIENTIST
BRITISH · ENGLAND · Age 55
Also on 1 other board
Former
director · Resigned 20/04/2026
Persons with Significant Control
Bgf Investment Management Limited
13-15, York Buildings, London, WC2N 6JU
Reg: 10608481 · Companies House · Private Limited Company
Notified 15/11/2024
Former PSCs
Dr Edward Mcconachie Green
Ceased 31/07/2022
Dr Basil Arthur Omar
Ceased 15/10/2019
Charges1 outstanding
BGF NOMINEES LIMITED
Insolvency History1 case
Rebecca Jane Dacre (practitioner) · Kyle Ashford (practitioner)
CompanyRankvs 98+ SIC 72110 peers54
Show leaderboard
How is this score calculated?
Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.
Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.
Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.
One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.
Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.
Risk deductions
Going concern doubt: -10 pts
Outstanding charges: -10 pts
Insolvency history: -10 pts
Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.
Going Concern Doubt
secured and this indicates the existence of an uncertainty which may cast significant doubt about the company’s ability to continue as a going concern. 2.3 Revenue Revenue is recognised to the extent that it is probable that the economic benefits will flow to the Company and the revenue can be reliably measured. Revenue is measured as the fair valu
Key FinancialsYear ending 31/12/2024
Net Worth
£321k
Balance sheet strength
Cash
£1.1M
Cash in the bank
Net Current Assets
£1.2M
Working capital
Current Assets
£1.3M
Current Liabilities
£123k
Fixed Assets
£89k
Debtors
£289k
Profit After Tax
-£1.2M
Balance Sheet
EstimatesDerived
| Year | Current Ratio | Implied Profit |
|---|---|---|
| 2024 | 10.91 | -£559k |
| 2023 | 8.11 | — |
Derived from filed accounts. Not audited figures.